Get Ahead of the TPD Insights Shaping ASH 2025
Stay ahead of the curve with Beacon’s TPD Pre-Conference Report, the essential resource for anyone tracking TPD innovation ahead of ASH 2025. Our expert analysts have reviewed all accepted abstracts and identified 261 (222 clinical and 39 preclinical) that are linked to TPD drug development, spanning both clinical and preclinical activity.
This report highlights the most relevant data and links each abstract to its Beacon TPD record, helping you quickly navigate key programs, assess competitive activity, and prepare your ASH agenda with confidence.
Inside the report, you can expect:
- A comprehensive overview of the 261 TPD related abstracts
- A breakdown of the leading therapeutic classes across TPD development
- A review of abstracts separated by clinical and preclinical data
You May Also Be Interested In…
Learn More About TPD
- The Most Comprehensive Way to Search the TPD Drug Development Landscape: Unique search ontologies based on TPD drug and trial characteristics
- Market Leading Approach to TPD Preclinical & Clinical Data Curation: Manual curation of key TPD research and development data points by TPD research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search TPD company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
